Literature DB >> 34102169

Detection of bladder cancer with aberrantly fucosylated ITGA3.

Md Khirul Islam1, Parvez Syed2, Bert Dhondt3, Kamlesh Gidwani4, Kim Pettersson4, Urpo Lamminmäki4, Janne Leivo4.   

Abstract

We describe a simple, non-invasive assay to identify fucosylated-glycoisoform of integrin alpha-3 (ITGA3) directly from unprocessed urine. ITGA3 was detected directly from the urine of bladder cancer (BlCa) (n = 13) and benign prostatic hyperplasia (BPH) (n = 9) patients with the use of lectins coated on europium-doped-nanoparticles (Eu3+-NPs). Lectin Ulex europaeus agglutinin-I (UEA) showed enhanced binding with BlCa-derived ITGA3. The evaluation with individual samples showed that a glycovariant ITGA3-UEA assay could significantly discriminate BlCa from BPH patients (p = 0.007). The detection of aberrantly fucosylated-isoform of ITGA3 from urine can be used to distinguish BlCa from age-matched benign controls in a simple sandwich assay.
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bladder cancer; Glycosylations; ITGA3; Integrin; UEA-lectin; Urine

Mesh:

Substances:

Year:  2021        PMID: 34102169     DOI: 10.1016/j.ab.2021.114283

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  2 in total

Review 1.  A Liquid Biopsy in Bladder Cancer-The Current Landscape in Urinary Biomarkers.

Authors:  Milena Matuszczak; Adam Kiljańczyk; Maciej Salagierski
Journal:  Int J Mol Sci       Date:  2022-08-02       Impact factor: 6.208

Review 2.  Fucosylation in Urological Cancers.

Authors:  Kazutoshi Fujita; Koji Hatano; Mamoru Hashimoto; Eisuke Tomiyama; Eiji Miyoshi; Norio Nonomura; Hirotsugu Uemura
Journal:  Int J Mol Sci       Date:  2021-12-11       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.